加味千金苇茎汤对急性加重期慢阻肺的临床价值

The Clinical Value of Modified Qianjin Weijing Decoction on Acute Exacerbation of Chronic Obstructive Pulmonary Disease

目的探讨加味千金苇茎汤对慢性阻塞性肺疾病急性加重期的临床价值。方法本次医学研究选择我院呼吸内科2014年1月—2015年12月之间收治的80例慢性阻塞性肺疾病急性加重期患者为观察对象,随机将其分为对照组和实验组,两组均接受常规药物治疗,实验组同时接受加味千金苇茎汤治疗,比较分析两组患者临床疗效。结果实验组患者临床治疗效果明显优于对照组,两组对比统计学差异明显,P<0.05;两组患者经过治疗后血浆sRAGE和AGEs浓度分别比较,差异均有统计学差异,P<0.05。结论慢性阻塞性肺疾病急性加重期患者接受加味千金苇茎汤治疗,具有较为满意的效果,值得推广应用。

Objective To investigate the clinical value of modified Qianjin Weijing decoction on acute exacerbation of chronic obstructive pulmonary disease. Methods 80 cases of patients with acute exacerbation of chronic obstructive pulmonary disease admitted to our hospital from January 2014 to December 2015 were selected as the observation objects,and they were randomly divided into control group and experimental group. The two groups underwent routine drug treatment. The experimental group also received modified Qianjin Weijing decoction. The clinical curative effect of the two groups was compared and analyzed. Results The clinical therapeutic effect of the experimental group was significantly better than that of the control group（ P 〈 0. 05）. The plasma concentration of sRAGE and AGEs in two groups were significantly different,and the difference had statistical significance（ P 〈 0. 05）. Conclusion Patients with acute exacerbation of chronic obstructive pulmonary disease received modified Qianjin Weijing decoction had satisfactory effect. It is worthy of popularization and application.